Balanced news tone
News Sentiment
AVR sentiment intelligence
Anteris Technologies Global Corp. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-4.6% over one week, +6.8% over four weeks, trend active, and materially above fair value.
Anteris Technologies files form S-3 to register 5.39M shares via warrants
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Anteris Technologies files form S-3 to register 5.39M shares via warrants
Anteris Technologies has filed a form S-3 with the SEC to register 5.39 million ordinary shares. These shares are to be issued upon the exercise of outstanding warrants, as detailed in an exhibit to the filing.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 00:09
- Source
- MSN
Anteris Technologies Global Corp. (AVR) registers 5.39M shares from warrants
Anteris Technologies Global Corp. (AVR) has filed a Form S-3 prospectus to register up to 5.39 million shares of common stock, including over 3 million CHESS Depositary Interests (CDIs), which are issuable upon the exercise of outstanding warrants. The company anticipates receivi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 12:11
- Source
- Stock Titan
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026
Anteris Technologies Global Corp. (ASX: AVR) has reported a net reduction of 51,701 CHESS Depositary Interests (CDIs) in June 2026, totaling 15,193,455 CDIs. This reduction is attributed to investors migrating their holdings from the ASX to common stock on the Nasdaq, increasing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 09:40
- Source
- Kalkine
Anteris Technologies Files Offering of Up to 5.39 Million Shares
Anteris Technologies has filed an offering to sell up to 5.39 million shares. This move suggests the company is looking to raise capital through the sale of its stock. The filing will be of interest to investors tracking the company's financial strategies and potential dilution.
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 01 Jul 2026 21:39
- Source
- Moomoo
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Small Cap Comp Value Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been added to the Russell Small Cap Comp Value Benchmark as of June 28, 2026. This addition is part of several rebalancing announcements, which also saw the company added to other Russell Value benchmarks and dropped from Russe
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 30 Jun 2026 11:39
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been added to the Russell 3000 Value Benchmark, among other Russell indices, and also recently to the S&P Healthcare Equipment Select Industry Index. The company is focused on cardiac care, specializing in structural heart solu
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 29 Jun 2026 23:10
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been added to the Russell 2000 Value Benchmark Index. This news follows a series of updates, including its prior inclusion in the S&P Healthcare Equipment Select Industry Index and its removal from several growth-oriented Russe
- Tone
- Positive 68/100
- Event
- Market update
- Published
- 29 Jun 2026 16:11
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been added to the Russell Microcap Value Benchmark Index. The company is a structural heart company focused on providing cardiac care through advancements like its DurAVR Transcatheter Heart Valve System. This news comes alongs
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 29 Jun 2026 12:41
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been removed from the Russell Microcap Growth Benchmark Index. This change highlights a shift in its index classification, occurring simultaneously with its inclusion in other Russell indices, such as the Russell Microcap Value
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 29 Jun 2026 12:41
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been removed from the Russell 2000 Growth Benchmark. This news comes alongside other recent index adjustments for the company, including being added to the Russell Microcap Value and Russell 2000 Value benchmarks, but also drop
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 29 Jun 2026 11:11
- Source
- marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been removed from the Russell 3000E Growth Benchmark, as reported by S&P Capital IQ. This news follows a series of other index adjustments for the company on the same day, including its addition to the Russell Microcap Value an
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 29 Jun 2026 09:11
- Source
- www.marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000E Value Benchmark
Anteris Technologies Global Corp. (NasdaqGM:AVR) has been added to the Russell 3000E Value Benchmark. This news follows several other adjustments to benchmark indices for Anteris, including additions to Russell 2000 Value and Russell 3000 Value benchmarks, and removals from relat
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 28 Jun 2026 22:39
- Source
- www.marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR
This page provides financial data for Anteris Technologies Global Corp. (NASDAQ: AVR), specifically focusing on its forward price-to-earnings ratio. The content is primarily a data placeholder from TradingView, indicating that specific financial figures for the period were not tr
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 17:41
- Source
- TradingView
Enterprise value to revenue forward of Anteris Technologies Global Corp. – NASDAQ:AVR
This article provides financial information for Anteris Technologies Global Corp. (NASDAQ:AVR), specifically its enterprise value to revenue forward. The content is hosted on TradingView and includes general market and company-specific data without detailed analysis or news.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 00:39
- Source
- TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR
This article provides financial information for Anteris Technologies Global Corp. (NASDAQ: AVR) focusing on its enterprise value to EBITDA forward. It indicates the stock market status as closed with no recent trades, and directs users to various financial, news, and technical da
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 13:37
- Source
- TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR)
This article provides an overview of Anteris Technologies Global Corp. (NASDAQ:AVR) stock, including its current price, market capitalization, and historical performance. It details financial actuals and estimates for earnings and revenue, analyst forecasts, and key financial met
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 26 Jun 2026 17:41
- Source
- TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR
The article focuses on the "Price to sales forward" financial metric for Anteris Technologies Global Corp. (NASDAQ: AVR). It provides an overview of the company's financial data as found on TradingView, indicating that the market was closed at the time of publication with no trad
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 02:10
- Source
- TradingView
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis
Anteris Technologies Global Corp (AVR) has a current financial score of 6.51, placing it 153rd out of 203 companies in the Healthcare Equipment & Supplies industry. The company's financial status is considered robust, but its operating efficiency is low. In its latest quarter, re
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jun 2026 06:40
- Source
- TradingKey
Anteris Technologies (AVR) Proxy filing Summary
Anteris Technologies (AVR) has postponed its Special Meeting of Stockholders from September 11, 2025, to September 18, 2025, to encourage broader shareholder participation, with the record date for voting remaining August 11, 2025. The meeting will be held virtually, and the Boar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 04:10
- Source
- Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence
This article provides an "Institutional Confidence" score for Anteris Technologies Global Corp (AVR), showing it has remained at 3.00 as of June 18, 2026. It lists key institutional shareholders and their shareholdings, noting significant changes in a few like L1 Capital Pty Ltd.
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 18 Jun 2026 03:16
- Source
- TradingKey
Anteris Technologies Global Corp
This article provides a revenue breakdown for Anteris Technologies Global Corp (AVR), detailing its regional revenue contributions. As of the latest update, relevant data for FY2025 has not been disclosed, but for previous periods, the United States accounted for the majority of
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 01:09
- Source
- TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Anteris Technologies Global Corp (AVR) focusing on its dividend and stock split history. It indicates that the company has not distributed any dividends over the past five years and has no recorded stock splits. The page also presents current
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 18 Jun 2026 01:09
- Source
- TradingKey
TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:05
- Source
- PR Newswire
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares
Anteris Technologies Global Corp. director David B. Roberts exercised 17,580 restricted stock units (RSUs) into common stock on June 7, 2026, as part of his equity compensation. This conversion means he now directly holds 17,580 common shares, with 35,162 RSUs remaining from an o
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 00:40
- Source
- Stock Titan
[Form 4] Anteris Technologies Global Corp. Insider Trading Activity
This article reports on insider trading activity at Anteris Technologies Global Corp. (AVR) based on a recent SEC Form 4 filing. Director Gregory S. Moss exercised 17,580 Restricted Stock Units, converting them into common stock. The filing details the transaction, the vesting sc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 01:40
- Source
- Stock Titan
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6%
Anteris Technologies has secured regulatory approval from the French National Agency for Medicines and Health Products Safety (ANSM) to begin recruitment for its DurAVR THV trial, Paradigm, in France. While this approval is a significant step, the company's shares fell 6% followi
- Tone
- Negative 39/100
- Event
- Regulatory and legal
- Published
- 09 Jun 2026 14:09
- Source
- Moomoo
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 23:22
- Source
- Proactive
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial
Anteris Technologies Global Corp has received regulatory clearance from France for its Duravr Paradigm Global Pivotal Trial. The article is very short, indicating that this is a significant step for the company's cardiac treatment development. Further details about the trial's sc
- Tone
- Positive 90/100
- Event
- Regulatory and legal
- Published
- 08 Jun 2026 23:39
- Source
- TradingView
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Technologies Global Corp. has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) for its DurAVR® Transcatheter Heart Valve (THV) global pivotal trial, known as the PARADIGM Trial. This clearance allows patien
- Tone
- Positive 73/100
- Event
- Regulatory and legal
- Published
- 08 Jun 2026 23:39
- Source
- GlobeNewswire
Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 08 Jun 2026 11:02
- Source
- MT Newswires